KR920005988A - 아라키돈산 대사를 억제하는 디페닐 화합물 및 약제학적 조성물에서의 이들의 용도 - Google Patents
아라키돈산 대사를 억제하는 디페닐 화합물 및 약제학적 조성물에서의 이들의 용도 Download PDFInfo
- Publication number
- KR920005988A KR920005988A KR1019910015407A KR910015407A KR920005988A KR 920005988 A KR920005988 A KR 920005988A KR 1019910015407 A KR1019910015407 A KR 1019910015407A KR 910015407 A KR910015407 A KR 910015407A KR 920005988 A KR920005988 A KR 920005988A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- compound
- formula
- allergic
- chlorine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/065—Diphenyl-substituted acyclic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/06—Phenols the aromatic ring being substituted by nitro groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 일정하게 인공호흡시키는 동안의 시간에 대한 대조군 동물(n=6) 및 실험하기 2시간 전에 펜티클로르 100mg/kg을 경구투여하여 예비처리한 실험 동물(n=6)에 대한 출발값의 %로서의 1회 호흡되는 숨의 용적(tidal volume)을 도시한 것이다.
제2도는 일정하게 인공호흡시키는 동안의 시간에 대한 대조군 동물(n=6) 및 실험하기 2시간 전에 펜티클로르 100mg/kg을 경구투여하여 예비처리한 실험동물(n=6)에 대한 초기값.
Claims (10)
- 다음 일반식(Ⅰ)의 화합물을 포함하는 약제학적 조성물.상기식에서, X는 산소, 황 또는 -CH2-이고, Y는 염소 또는 브롬이며, Z는 SO2H, NO2또는 C1-C4알킬 라디칼이고, r은 0 내지 3의 수이며, o는 0 내지 3의 수이고, p는 0 또는 1의 수이며, m은 1 또는 2의 수이고, n은 0 또는 1의 수이다.
- 제1항에 있어서, 다음 일반식(Ⅰ)의 화합물을 포함하는 약제학적 조성물.상기식에서, X는 산소, 황 또는 -CH2-이고, Y는 염소 또는 브롬이며, Z는 SO2H, NO2또는 C1-C4알킬 라디칼이고, r은 0 내지 3의 수이며, o는 0 내지 3의 수이고, p는 0 또는 1의 수이며, m은 1 또는 2의 수이고, n은 0 또는 1의 수이다.
- 제2항에 있어서, X가 산소, 황 또는 -CH2-이고, Y가 염소 또는 브롬이며, m이 0이고, n이 0 또는 1이며, o는 1 또는 2이고, r이 1 또는 2이며 p가 0인 일반식(Ⅰ)의 화합물을 포함하는 약제학적 조성물.
- 제2항에 있어서, X가 산소이고, Y가 염소이며, m이 0이고, n이 0이며, o가 1이고, r이 2이며 p가 0인 일반식(Ⅰ)의 화합물을 포함하는 약제학적 조성물.
- 제1항 내지 제4항 중의 어느 한 항에 있어서, 총혼합물을 기준하여, 0.01 내지 15중량%, 바람직하게는 0.1 내지 4중량%의 양으로 일반식(Ⅰ)의 화합물을 포함하는 약제학적 조성물.
- 제1항 내지 제5항 중의 어느 한 항에 있어서, 침투 촉진제를 부가적으로 포함하는 약제학적 조성물.
- 제6항에 있어서, 침투 촉진제로서 우레아, 프로필렌 글리콜 또는 올레산을 포함하는 약제학적 조성물.
- 제1항 내지 제4항 중의 어느 한 항에 있어서, 소염성, 항건선성, 세포증식-조절성, 항알레르기성, 진경성 위보호성, 또는 항천식성 활성성분중의 하나 이상을 부가적으로 포함하는 약제학적 조성물.
- 염증성, 알레르기성 및 진경성 질환, 및 건선, 기관지천식 및 세포증식 장해를 일으키는 질병을 국부적 및/또는 흡입성 치료하기 위한 제1항 내지 제8항중의 어느 한 항에 따르는 약제학적 조성물의 용도.
- 염증성, 알레르기성 및 진경성 질환, 및 건선, 기관지천식 및 세포증식 장해를 질병을 치료하기 위한 약제학적 제제를 제조하는데 있어서의 제1항 내지 제4항 중의 어느 한 항에 기술된 화합물의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2875/90-3 | 1990-09-05 | ||
CH287590 | 1990-09-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920005988A true KR920005988A (ko) | 1992-04-27 |
KR100201749B1 KR100201749B1 (ko) | 1999-06-15 |
Family
ID=4243541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910015407A KR100201749B1 (ko) | 1990-09-05 | 1991-09-04 | 아라키돈산 대사를 억제하는 디페닐 화합물을 포함하는 약제학적 조성물_ |
Country Status (22)
Country | Link |
---|---|
US (1) | US5185377A (ko) |
EP (1) | EP0474597B1 (ko) |
JP (1) | JP3264950B2 (ko) |
KR (1) | KR100201749B1 (ko) |
AT (1) | ATE156353T1 (ko) |
AU (1) | AU645599B2 (ko) |
CA (1) | CA2050569C (ko) |
CZ (1) | CZ279624B6 (ko) |
DE (1) | DE59108814D1 (ko) |
DK (1) | DK0474597T3 (ko) |
ES (1) | ES2106770T3 (ko) |
FI (1) | FI914185A (ko) |
GR (1) | GR3024440T3 (ko) |
HU (2) | HUT58998A (ko) |
IE (1) | IE913110A1 (ko) |
IL (1) | IL99376A (ko) |
MX (1) | MX9100917A (ko) |
NO (1) | NO913472L (ko) |
PT (1) | PT98874B (ko) |
RU (1) | RU2060731C1 (ko) |
SK (1) | SK279104B6 (ko) |
ZA (1) | ZA917005B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9117140D0 (en) * | 1991-08-08 | 1991-09-25 | Unilever Plc | Treatment of periodontitis |
US6440395B1 (en) | 1992-06-22 | 2002-08-27 | Barry M. Libin | Antiplaque mouth rinse |
CH686285A5 (fr) * | 1992-08-06 | 1996-02-29 | Beiersdorf Ag | Preparation cosmetique ou pharmaceutique servant a retarder le vieillissement de la peau humaine. |
US5880146A (en) * | 1995-06-07 | 1999-03-09 | Fuji Immunopharmaceuticals Corporation | Inhibition of IL-12-induced IFN-γ synthesis by specific bis-phenol compounds as a method of immune modulation |
DE19680594D2 (de) * | 1995-07-20 | 1997-09-18 | Uwe Juergens | Verwendung eines nicht-steroidalen Antiphlogistikums zur topischen und systemischen Behandlung der akutven und chronischen polypoiden Rhinosinusitis |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US6108850A (en) * | 1997-06-03 | 2000-08-29 | Mclaughlin; Gerald | Accelerated method and instrumentation for whitening teeth |
DE19834355A1 (de) * | 1998-07-30 | 2000-02-03 | Henkel Kgaa | Entzündungshemmende Zahnpflegemittel |
US7566740B2 (en) * | 1998-10-06 | 2009-07-28 | Bml Pharmaceuticals, Inc. | Method of treating mucositis |
DE69931182T2 (de) * | 1999-06-23 | 2007-03-01 | Jawaharlal Nehru Centre For Advanced Scientific Research | Verwendung von triclosan als antimalariamittel |
WO2002050008A2 (en) * | 2000-12-20 | 2002-06-27 | Warner-Lambert Company Llc | Non-halogenated phenoxy and/or benzyloxy phenols and antimicrobial compositions containing them |
US20030229149A1 (en) * | 2002-05-28 | 2003-12-11 | Werner Baschong | Anti-inflammatory agents |
EP1366763A1 (en) * | 2002-05-28 | 2003-12-03 | Ciba SC Holding AG | Hydroxy diphenyl ether compounds as anti-inflammatory agents |
EP2600864B1 (en) * | 2010-08-04 | 2019-01-09 | University Of Virginia Patent Foundation | Compositions and methods for treating inflammatory diseases |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4512987A (en) * | 1982-07-15 | 1985-04-23 | Ciba-Geigy Corporation | New pharmaceutical preparations |
GB2148116B (en) * | 1983-10-27 | 1986-07-30 | Ciba Geigy Ag | Topical steroid preparations |
GB8526093D0 (en) * | 1985-10-22 | 1985-11-27 | Beecham Group Plc | Composition |
US4735802A (en) * | 1986-05-05 | 1988-04-05 | Le Bich N | Topical dermatological composition and method of treatment |
US4942029A (en) * | 1986-09-19 | 1990-07-17 | Smith & Nephew United, Inc. | Medicated skin preparation |
GB8629640D0 (en) * | 1986-12-11 | 1987-01-21 | Beecham Group Plc | Composition & method |
GB8718026D0 (en) * | 1987-07-29 | 1987-09-03 | Smith & Nephew Ass | Pharmaceutical composition |
AU610906B2 (en) * | 1987-07-31 | 1991-05-30 | Sumitomo Chemical Company, Limited | Method for preventing harm from bloodsucking insects |
-
1991
- 1991-08-27 DE DE59108814T patent/DE59108814D1/de not_active Expired - Lifetime
- 1991-08-27 EP EP91810685A patent/EP0474597B1/de not_active Expired - Lifetime
- 1991-08-27 DK DK91810685.7T patent/DK0474597T3/da active
- 1991-08-27 ES ES91810685T patent/ES2106770T3/es not_active Expired - Lifetime
- 1991-08-27 AT AT91810685T patent/ATE156353T1/de not_active IP Right Cessation
- 1991-09-03 MX MX9100917A patent/MX9100917A/es not_active IP Right Cessation
- 1991-09-03 IL IL9937691A patent/IL99376A/en not_active IP Right Cessation
- 1991-09-03 CA CA002050569A patent/CA2050569C/en not_active Expired - Lifetime
- 1991-09-04 ZA ZA917005A patent/ZA917005B/xx unknown
- 1991-09-04 AU AU83640/91A patent/AU645599B2/en not_active Ceased
- 1991-09-04 IE IE311091A patent/IE913110A1/en not_active IP Right Cessation
- 1991-09-04 NO NO91913472A patent/NO913472L/no unknown
- 1991-09-04 KR KR1019910015407A patent/KR100201749B1/ko not_active IP Right Cessation
- 1991-09-04 US US07/754,788 patent/US5185377A/en not_active Expired - Lifetime
- 1991-09-04 HU HU912866A patent/HUT58998A/hu unknown
- 1991-09-04 SK SK2718-91A patent/SK279104B6/sk unknown
- 1991-09-04 FI FI914185A patent/FI914185A/fi unknown
- 1991-09-04 CZ CS912718A patent/CZ279624B6/cs unknown
- 1991-09-04 RU SU915001448A patent/RU2060731C1/ru active
- 1991-09-05 JP JP22563191A patent/JP3264950B2/ja not_active Expired - Lifetime
- 1991-09-05 PT PT98874A patent/PT98874B/pt not_active IP Right Cessation
-
1995
- 1995-06-21 HU HU95P/P00310P patent/HU211292A9/hu unknown
-
1997
- 1997-08-13 GR GR970402083T patent/GR3024440T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT98874A (pt) | 1992-07-31 |
GR3024440T3 (en) | 1997-11-28 |
JP3264950B2 (ja) | 2002-03-11 |
PT98874B (pt) | 1999-02-26 |
MX9100917A (es) | 1992-05-04 |
EP0474597A3 (en) | 1992-07-01 |
RU2060731C1 (ru) | 1996-05-27 |
FI914185A0 (fi) | 1991-09-04 |
NO913472L (no) | 1992-03-06 |
CA2050569C (en) | 2004-01-27 |
NO913472D0 (no) | 1991-09-04 |
HU211292A9 (en) | 1995-11-28 |
DK0474597T3 (da) | 1997-10-20 |
CA2050569A1 (en) | 1992-03-06 |
ZA917005B (en) | 1992-04-29 |
CZ279624B6 (cs) | 1995-05-17 |
IL99376A (en) | 1996-01-19 |
KR100201749B1 (ko) | 1999-06-15 |
EP0474597A2 (de) | 1992-03-11 |
EP0474597B1 (de) | 1997-08-06 |
IL99376A0 (en) | 1992-08-18 |
JPH04257517A (ja) | 1992-09-11 |
ES2106770T3 (es) | 1997-11-16 |
FI914185A (fi) | 1992-03-06 |
AU8364091A (en) | 1992-03-12 |
IE913110A1 (en) | 1992-03-11 |
CS271891A3 (en) | 1992-03-18 |
HUT58998A (en) | 1992-04-28 |
ATE156353T1 (de) | 1997-08-15 |
SK279104B6 (sk) | 1998-06-03 |
AU645599B2 (en) | 1994-01-20 |
DE59108814D1 (de) | 1997-09-11 |
US5185377A (en) | 1993-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920005988A (ko) | 아라키돈산 대사를 억제하는 디페닐 화합물 및 약제학적 조성물에서의 이들의 용도 | |
KR890011837A (ko) | 디데하이드로 비타민 d₃유도체 | |
CA2050812A1 (en) | Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions, and methods for the treatment of inflammatory conditions | |
BR9406979A (pt) | Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal | |
KR830006174A (ko) | 기관지 항경련성 화합물 제조방법 | |
KR850700136A (ko) | 신규 구아닌 유도체 | |
CA2471578A1 (en) | Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments | |
US5219880A (en) | Treatment of viral tumors and hemorrhoids with artemisinin and derivatives | |
KR910004653A (ko) | 스테로이드 5-α-환원효소의 억제제로서의 7-케토 또는 히드록시 3,5-디엔 스테로이드 | |
NO810479L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater | |
EP0490379A3 (de) | Diaminosäurederivate und pharmazeutische Zusammensetzungen | |
ES2059755T3 (es) | Derivados organicos de hidrazina para uso farmaceutico. | |
KR900016135A (ko) | 피부 및 점막-상피의 질환 치료용 4-퀴놀린 카복실산 유도체 | |
KR20020050254A (ko) | 베타 2 (β2) 아드레날린 수용체 작용제 및 류코트리엔수용체 길항제를 포함하는 신규한 조합물 | |
CA2367138A1 (en) | Anti-inflammatory uses of manzamines | |
KR900701278A (ko) | 바이러스 감염 치료용 담즙산 | |
JPS6160815B2 (ko) | ||
ATE18761T1 (de) | Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen. | |
DE69434002T2 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
KR900701273A (ko) | 진토성 에르골린 유도체 | |
EP1305016B1 (de) | Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis) | |
KR950702830A (ko) | 치환된 아자스피란을 사용한 건선 치료 방법(methods of treating psoriasis employing substituted azaspiranes) | |
KR927003573A (ko) | 치료학상 활성인 불소 치환된 벤즈이미다졸, 그의 제조 방법 및 그의 용도 | |
US4296124A (en) | Pharmaceutical methods | |
KR880001626A (ko) | 1,3-프로판디아민 유도체, 그 제조방법 및 그것을 함유하는 약학조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |